These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 15383417

  • 1. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
    Tamura M, Oda M, Matsumoto I, Tsunezuka Y, Kawakami K, Ohta Y, Watanabe G.
    Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
    [Abstract] [Full Text] [Related]

  • 2. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 3. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
    Zhang HZ, Wei YP, Li HG, Wang M, Liu JG, Wu C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep 15; 26(9):1307-10. PubMed ID: 16982442
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
    Laack E, Scheffler A, Burkholder I, Boeters I, Andritzky B, Schuch G, Görn M, Vohwinkel G, Edler L, Fiedler W, Hossfeld DK.
    Lung Cancer; 2005 Oct 15; 50(1):51-8. PubMed ID: 15992959
    [Abstract] [Full Text] [Related]

  • 5. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A.
    Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294
    [Abstract] [Full Text] [Related]

  • 6. [Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer].
    Zhao J, Liu XY, Zhang QY, Jiang W.
    Zhonghua Zhong Liu Za Zhi; 2005 Nov 03; 27(11):676-9. PubMed ID: 16438890
    [Abstract] [Full Text] [Related]

  • 7. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
    Shou Y, Hirano T, Gong Y, Kato Y, Yoshida K, Ohira T, Ikeda N, Konaka C, Ebihara Y, Zhao F, Kato H.
    Br J Cancer; 2001 Nov 30; 85(11):1706-12. PubMed ID: 11742492
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer].
    Li J, Li BL, Zhang HQ, Xu SF, Liu ZD, Yue WT, Han Y.
    Zhonghua Yi Xue Za Zhi; 2008 Nov 18; 88(42):2982-5. PubMed ID: 19080076
    [Abstract] [Full Text] [Related]

  • 9. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
    Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S.
    Cancer; 2005 Feb 15; 103(4):724-30. PubMed ID: 15637689
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 11. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE, Oliveira DT, Nonogaki S, Landman G, Carvalho AL, Kowalski LP.
    Int J Oral Maxillofac Surg; 2008 Apr 15; 37(4):372-8. PubMed ID: 18295452
    [Abstract] [Full Text] [Related]

  • 12. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H.
    Ai Zheng; 2005 Sep 15; 24(9):1132-5. PubMed ID: 16159440
    [Abstract] [Full Text] [Related]

  • 13. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer.
    Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Ohta Y, Watanabe G.
    Chest; 2004 Aug 15; 126(2):342-6. PubMed ID: 15302715
    [Abstract] [Full Text] [Related]

  • 14. [Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance].
    Zhang HZ, Hua P, Li HG, Lü ZQ, Zeng YJ, Liu JG, Zeng H.
    Zhonghua Zhong Liu Za Zhi; 2005 Dec 15; 27(12):734-7. PubMed ID: 16483484
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M.
    Lung Cancer; 2007 Nov 15; 58(2):205-13. PubMed ID: 17686546
    [Abstract] [Full Text] [Related]

  • 16. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY, Wu MS, Chiang EP, Chen YJ, Chen CJ, Chi NH, Shih YT, Chen GH, Lin JT.
    Clin Cancer Res; 2007 Apr 01; 13(7):2054-60. PubMed ID: 17404086
    [Abstract] [Full Text] [Related]

  • 17. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Maekawa S, Iwasaki A, Shirakusa T, Enatsu S, Kawakami T, Kuroki M, Kuroki M.
    Anticancer Res; 2007 Apr 01; 27(6A):3735-41. PubMed ID: 17970036
    [Abstract] [Full Text] [Related]

  • 18. [The estimation of serum concentration of vascular endothelial growth factor in patients with non-small cell lung cancer].
    Kopczyńska E, Dancewicz M, Kowalewski J, Kardymowicz H, Tyrakowski T.
    Pol Merkur Lekarski; 2007 Jun 01; 22(132):536-8. PubMed ID: 17874624
    [Abstract] [Full Text] [Related]

  • 19. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B.
    Clin Cancer Res; 2009 Mar 01; 15(5):1741-6. PubMed ID: 19240177
    [Abstract] [Full Text] [Related]

  • 20. Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.
    Kimura H, Kato H, Tanaka N, Inose T, Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2008 Mar 01; 28(1A):165-9. PubMed ID: 18383841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.